Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.
Saved in:
| Title: | Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS. |
|---|---|
| Authors: | Arnold DL; Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.; Neurology and Neurosurgery, NeuroRx Research, Montreal, QC, Canada., Kolind S; Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Assemlal HE; Neurology and Neurosurgery, NeuroRx Research, Montreal, QC, Canada., Bar-Or A; Department of Neurology and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Inglese M; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland., Parmar K; Research Center for Clinical Neuroimmunology and Neuroscience and MS Center, Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland.; Reha Rheinfelden, Rheinfelden, Switzerland., Sprenger T; Department of Neurology, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany., Traboulsee A; Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Vavasour IM; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Wolinsky JS; Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA., Bernasconi C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Bonati U; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Magon S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Tackenberg B; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gaetano L; F. Hoffmann-La Roche Ltd, Basel, Switzerland. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2025 Jun; Vol. 31 (7), pp. 821-832. Date of Electronic Publication: 2025 Apr 16. |
| Publication Type: | Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585251325086 |
